Day One Biopharmaceuticals (DAWN) Research & Development: 2023-2025
Historic Research & Development for Day One Biopharmaceuticals (DAWN) over the last 3 years, with Sep 2025 value amounting to $31.4 million.
- Day One Biopharmaceuticals' Research & Development fell 6.39% to $31.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $169.0 million, marking a year-over-year decrease of 16.84%. This contributed to the annual value of $227.7 million for FY2024, which is 74.46% up from last year.
- As of Q3 2025, Day One Biopharmaceuticals' Research & Development stood at $31.4 million, which was down 13.08% from $36.1 million recorded in Q2 2025.
- In the past 5 years, Day One Biopharmaceuticals' Research & Development registered a high of $92.1 million during Q2 2024, and its lowest value of $27.8 million during Q2 2023.
- Its 3-year average for Research & Development is $43.3 million, with a median of $36.7 million in 2023.
- In the last 5 years, Day One Biopharmaceuticals' Research & Development skyrocketed by 230.98% in 2024 and then tumbled by 60.75% in 2025.
- Day One Biopharmaceuticals' Research & Development (Quarterly) stood at $37.3 million in 2023, then soared by 65.53% to $61.8 million in 2024, then dropped by 6.39% to $31.4 million in 2025.
- Its last three reported values are $31.4 million in Q3 2025, $36.1 million for Q2 2025, and $39.6 million during Q1 2025.